Health Care
Solventum delivered strong organic revenue growth in Q2 FY2026 supported by advanced orders and tariff refunds, but rising costs and weak cash flow pressured operating performance.
Key risk: Health Information Systems separation uncertainty
The review of strategic alternatives for the health information systems business may not result in a transaction, could divert management attention, create customer uncertainty, and incur costs regardless of outcome.
Other Health Care Technology companies